Skip to content

    INTEGRA LIFESCIENCES HOLDINGS (IART) stock price & financials

    View IART earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+13.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $380.83M
    $442.65M
    $382.65M
    $415.61M
    $402.06M
    +5.6%
    $434.93M
    -1.7%
    $391.92M
    +2.4%
    $418.76M
    +0.8%
    Stable
    Operating Profit
    -$8.15M
    $35.63M
    -$15.50M
    -$512.67M
    $11.76M
    $23.04M
    -35.3%
    $11.47M
    $19.29M
    Weakening
    Net Profit
    -$10.70M
    $19.43M
    -$25.29M
    -$484.07M
    -$5.40M
    +49.5%
    -$1.70M
    -108.8%
    -$4.62M
    +81.7%
    $4.48M
    Weakening
    EPS
    $-0.14
    $-0.33
    $-6.31
    $-0.07
    +50.0%
    $-0.06
    +81.8%
    $0.06
    Strengthening
    Other Income
    Interest
    $19.37M
    $18.98M
    $18.82M
    $21.04M
    $22.73M
    +17.3%
    $23.67M
    +24.7%
    $22.46M
    +19.4%
    $22.99M
    +9.3%
    Strengthening
    Depreciation
    Profit before Tax
    -$20.36M
    $22.54M
    -$30.04M
    -$530.95M
    -$6.82M
    +66.5%
    $4.31M
    -80.9%
    -$2.41M
    +92.0%
    $4.74M
    Strengthening
    MarginsOPM
    -2.1%
    8.1%
    -4.0%
    -123.4%
    2.9%
    5.3%
    -34.2%
    2.9%
    4.6%
    Weakening
    Tax
    47.5%
    13.8%
    15.8%
    8.8%
    20.8%
    -56.2%
    139.5%
    +912.6%
    -91.7%
    -680.5%
    5.5%
    -37.5%
    Strengthening
    ReturnsROIC
    -2.5%
    4.6%
    -6.0%
    -114.1%
    -1.3%
    +49.5%
    -0.4%
    -108.8%
    -1.1%
    +81.7%
    1.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$138.84M$198.91M$470.17M$513.45M$456.66M$276.40M$246.38M$235.05M$214.41M
    Short-Term Investments
    Total Current Assets$775.08M$858.17M$1.24B$1.15B$1.16B$1.06B$1.08B$1.16B$1.19B
    Net PP&E$300.11M$431.93M$371.16M$396.25M$459.59M$496.38M$549.76M$584.90M$583.29M
    Goodwill$926.48M$954.28M$932.37M$1.01B$1.04B$1.06B$1.10B$615.16M$611.14M
    Intangibles$1.08B$1.03B$989.44M$1.15B$1.13B$1.07B$1.21B$1.13B$1.08B
    Total Assets$3.11B$3.30B$3.62B$3.78B$3.89B$3.78B$4.04B$3.60B$3.56B
    LiabilitiesTotal Current Liabilities$262.55M$331.31M$401.01M$340.02M$320.91M$306.98M$922.13M$455.98M$330.88M
    Short-Term Debt
    Long-Term Debt$900.00M$877.50M$877.50M$843.75M$775.00M$775.00M$760.47M$726.56M$707.19M
    Long-Term Leases$97.50M$88.12M$90.33M$157.42M$166.85M$166.93M$163.06M$162.66M
    Total Liabilities$1.73B$1.89B$2.10B$2.10B$2.09B$2.19B$2.49B$2.56B$2.52B
    EquityCommon Stock & APIC$880.0K$887.0K$893.0K$896.0K$905.0K$909.0K$916.0K$923.0K$921.0K
    Retained Earnings$348.37M$398.57M$532.26M$698.57M$879.12M$946.86M$939.91M$423.44M$423.31M
    Total Equity$1.38B$1.42B$1.51B$1.68B$1.80B$1.59B$1.55B$1.04B$1.04B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$199.68M$231.43M$203.83M$312.43M$264.47M$139.96M$129.38M$50.38M$85.33M
    Cash from Investing-$49.70M-$162.67M-$68.07M-$161.44M-$58.58M-$94.18M-$390.81M-$108.06M-$108.63M
    Cash from Financing-$180.87M-$8.77M$121.63M-$98.23M-$251.95M-$229.93M$237.86M$28.34M$21.58M
    SummaryCapital Expenditure-$77.74M-$69.54M-$38.89M-$48.02M-$42.34M-$66.86M-$104.42M-$81.44M-$59.52M
    Free Cash Flow$121.94M$161.90M$164.94M$264.40M$222.13M$73.09M$24.96M-$31.05M$25.80M
    FCF Margin8.3%10.7%12.0%17.1%14.3%4.7%1.6%-1.9%1.6%

    Ratios